학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 71건 | 목록 1~10
Academic Journal
Smith MR; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.; Jegede OA; Dana Farber Cancer Institute, Boston, MA.; Martin P; Meyer Cancer Center, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY.; Till BG; Fred Hutchinson Cancer Center, Seattle, WA.; Parekh SS; Division of Hematology-Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.; Yang DT; Department of Pathology and Laboratory Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.; Hsi ED; Mayo Clinic, Rochester, MN.; Witzig T; Mayo Clinic, Rochester, MN.; Dave S; Department of Medicine, Duke University Medical Center, Durham, NC.; Scott D; BC Cancer Agency-Vancouver Cancer Centre, Vancouver, BC, Canada.; Hanson C; Mayo Clinic, Rochester, MN.; Kostakoglu Shields L; Department of Radiology, NYU Langone Health-Perlmutter Cancer Center, New York, NY.; Abdel-Samad N; The Moncton Hospital, Moncton, NB, Canada.; Casulo C; University of Rochester Medical Center-James P. Wilmot Cancer Center, Rochester, NY.; Bartlett NL; Washington University School of Medicine St. Louis and Siteman Cancer Center, St. Louis, MO.; Caimi PF; Case Comprehensive Cancer Center, Cleveland, OH.; Al Baghdadi T; St. Joseph Mercy Hospital, Ann Arbor, MI.; Blum KA; The Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.; Romer MD; Good Samaritan Hospital-Dayton, Kettering, OH.; Inwards DJ; Mayo Clinic, Rochester, MN.; Lerner RE; Frauenshuh Cancer Center and Park Nicollet Institute, Minneapolis, MN.; Wagner LI; The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Little RF; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Friedberg JW; University of Rochester Medical Center-James P. Wilmot Cancer Center, Rochester, NY.; Leonard JP; Meyer Cancer Center, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY.; Kahl BS; Washington University School of Medicine St. Louis and Siteman Cancer Center, St. Louis, MO.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Krakow EF; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Brault M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Summers C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.; Cunningham TM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Biernacki MA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Black RG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Woodward KB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Vartanian N; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kanaan SB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Yeh AC; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Dossa RG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Bar M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Dahlberg A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.; Till BG; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Denker AE; ElevateBio Technologies, Waltham, MA.; Yeung CCS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Maloney DG; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Riddell SR; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Greenberg PD; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Immunology, University of Washington School of Medicine, Seattle, WA.; Chapuis AG; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Newell EW; Vaccine and Infection Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA.; Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.; Bleakley M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Mo G; Department of Medicine, University of Washington, Seattle, Washington.; Lee SY; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Coffey DG; Department of Medicine, University of Washington, Seattle, Washington.; University of Miami, Miami, Florida.; Voillet V; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Kirsch IR; Adaptive Biotechnologies, Seattle, Washington.; Gottardo R; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington.; University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.; Smythe KS; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Yeung CCS; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Greenbaum A; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Green DJ; Department of Medicine, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Maloney DG; Department of Medicine, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Till BG; Department of Medicine, University of Washington, Seattle, Washington.; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Academic Journal
Banerjee R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Poh C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Kiem HP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Ho C; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: carrho@uw.edu.; Gopal AK; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Till BG; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Shadman M; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Lynch RC; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Cowan AJ; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Wu QV; Fred Hutchinson Cancer Center, Seattle, WA.; Voutsinas J; Fred Hutchinson Cancer Center, Seattle, WA.; Rasmussen HA; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA.; Blue K; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA.; Ujjani CS; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Cassaday RD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.; Fromm JR; Department of Laboratory Medicine, Division of Hematopathology, University of Washington, Seattle, WA.; Fang M; Fred Hutchinson Cancer Center, Seattle, WA.; Smith SD; Department of Internal Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA.
Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Academic Journal
Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Kimble EL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Wright JH; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Fiorenza S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Wu Q; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Yeung CCS; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.; Gazeau N; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Pender BS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kirchmeier DR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Torkelson A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Chutnik AN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Chapuis AG; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Green DJ; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Kiem HP; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Milano F; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Till BG; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Riddell SR; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Maloney DG; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Turtle CJ; Department of Medicine, University of Washington, Seattle, WA.; Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Albittar A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Huang JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kimble EL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Chapuis A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Kiem HP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Turtle CJ; Faculity of Medicine and Health, University of Sydney, Sydney, Australia.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Lee SY; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Lee DH; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Sun W; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Cervantes-Contreras F; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Basom RS; Genomics and Bioinformatics Shared Resource, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Wu F; Genomics and Bioinformatics Shared Resource, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Liu S; Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Rai R; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Mirzaei HR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; O'Steen S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Green DJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Shadman M; Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Till BG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA tillb@fredhutch.org.; Department of Medicine, University of Washington, Seattle, Washington, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Cowan AJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Pont MJ; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Sather BD; Juno Therapeutics, Seattle, WA, USA.; Turtle CJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Till BG; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Libby EN 3rd; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Coffey DG; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Tuazon SA; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Wood B; Department of Pathology, University of Washington, Seattle, WA, USA.; Gooley T; Statistics Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Wu VQ; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA; Statistics Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Voutsinas J; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA; Statistics Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Song X; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA; Statistics Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Shadman M; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Gauthier J; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Chapuis AG; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Milano F; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Maloney DG; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Riddell SR; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA.; Green DJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA; Immunotherapy Integrated Research Center, Fred Hutch Cancer Center, Seattle, WA, USA. Electronic address: dgreen@fredhutch.org.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
An M; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Wang W; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhang J; Department of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA.; Zhao L; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Huang H; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Yang Y; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Li T; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Han L; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Zhang X; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Qin P; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Wang Y; Department of Hepatobiliary Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Zhang M; Department of Hepatobiliary Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Cui H; Department of Hepatobiliary Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.; Gao Q; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. zlyygql0855@zzu.edu.cn.; Wang Z; Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. zlyywzb2118@zzu.edu.cn.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Till BG
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어